Skip Nav Destination
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis
Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor
Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma
Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma
Issue Archive
May 15 2003
Table of Contents
INSIDE BLOOD
REVIEW ARTICLES
CHEMOKINES
Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1
Ryan Reca,Dimitrios Mastellos,Marcin Majka,Leah Marquez,Janina Ratajczak,Silvia Franchini,Aleksandra Glodek,Marek Honczarenko,Lynn A. Spruce,Anna Janowska-Wieczorek,John D. Lambris,Mariusz Z. Ratajczak
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
Clinical Trials & Observations
Jorge E. Cortes,Moshe Talpaz,Francis Giles,Susan O'Brien,Mary Beth Rios,Jianqin Shan,Guillermo Garcia-Manero,Stefan Faderl,Deborah A. Thomas,William Wierda,Allessandra Ferrajoli,Sima Jeha,Hagop M. Kantarjian
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Clinical Trials & Observations
Bruce C. Bostrom,Martha R. Sensel,Harland N. Sather,Paul S. Gaynon,Mei K. La,Katherine Johnston,Gary R. Erdmann,Stuart Gold,Nyla A. Heerema,Raymond J. Hutchinson,Arthur J. Provisor,Michael E. Trigg
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20
Clinical Trials & Observations
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis
Clinical Trials & Observations
Anja Borgmann,Arend von Stackelberg,Reinhard Hartmann,Wolfram Ebell,Thomas Klingebiel,Christina Peters,Günter Henze,for the Berlin-Frankfurt-Münster Relapse Study Group
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
Clinical Trials & Observations
Eva Ösby,Hans Hagberg,Stein Kvaløy,Lasse Teerenhovi,Harald Anderson,Eva Cavallin-Ståhl,Harald Holte,John Myhre,Hannu Pertovaara,Magnus Björkholm,for the Nordic Lymphoma Group (NLG)
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression
Clinical Trials & Observations
John Shaughnessy,Joth Jacobson,Jeff Sawyer,Jason McCoy,Athanasios Fassas,Fenghuang Zhan,Klaus Bumm,Joshua Epstein,Elias Anaissie,Sundar Jagannath,David Vesole,David Siegel,Raman Desikan,Nikhil Munshi,Ashraf Badros,Erming Tian,Maurizio Zangari,Guido Tricot,John Crowley,Bart Barlogie
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment
Clinical Trials & Observations
Mary V. Relling,James M. Boyett,Javier G. Blanco,Susana Raimondi,Frederick G. Behm,John T. Sandlund,Gaston K. Rivera,Larry E. Kun,William E. Evans,Ching-Hon Pui
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis
Clinical Trials & Observations
Christian M. Zwaan,Dirk Reinhardt,Selim Corbacioglu,Elisabeth R. van Wering,Jos P. M. Bökkerink,Wim J. E. Tissing,Ulf Samuelsson,Jay Feingold,Ursula Creutzig,Gertjan J. L. Kaspers
Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor
Clinical Trials & Observations
Brief Report
ERRATA
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Hyperhomocysteinemia accelerates atherosclerosis in cystathionine β-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation
Hong Wang,XiaoHua Jiang,Fan Yang,John W. Gaubatz,Lang Ma,Mark J. Magera,XiaoFeng Yang,Peter B. Berger,William Durante,Henry J. Pownall,Andrew I. Schafer
Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B
Lingfei Xu,Cuihua Gao,Mark S. Sands,Shi-Rong Cai,Timothy C. Nichols,Dwight A. Bellinger,Robin A. Raymer,Stephanie McCorquodale,Katherine Parker Ponder
ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface: Presented in part as posters at the American Thoracic Society (ATS) Meeting, May 5-10, 2000, Toronto, ON, Canada.
Juan-Carlos Murciano,Silvia Muro,Lauren Koniaris,Melpo Christofidou-Solomidou,David W. Harshaw,Steven M. Albelda,D. Neil Granger,Douglas B. Cines,Vladimir R. Muzykantov
IMMUNOBIOLOGY
NEOPLASIA
CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras andjunD
Fotini Nicolaou,Jens M. Teodoridis,Heiyoung Park,Alexander Georgakis,Omid C. Farokhzad,Erwin P. Böttinger,Nicolas Da Silva,Philippe Rousselot,Christine Chomienne,Katalin Ferenczi,M. Amin Arnaout,C. Simon Shelley
Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations
Clinical Trials & Observations
Francisca I. Camacho,Patrocinio Algara,Antonia Rodrı́guez,Elena Ruı́z-Ballesteros,Manuela Mollejo,Nerea Martı́nez,José A. Martı́nez-Climent,Marcos González,Marisol Mateo,Alessia Caleo,Margarita Sánchez-Beato,J. Menárguez,Javier Garcı́a-Conde,Francesc Solé,Elı́as Campo,Miguel A. Piris
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma
Clinical Trials & Observations
Sarah H. Walsh,Mia Thorsélius,Anna Johnson,Ola Söderberg,Mats Jerkeman,Erik Björck,Inger Eriksson,Ulf Thunberg,Ola Landgren,Mats Ehinger,Eva Löfvenberg,Kristina Wallman,Gunilla Enblad,Birgitta Sander,Anna Porwit-MacDonald,Michael Dictor,Tor Olofsson,Christer Sundström,Göran Roos,Richard Rosenquist
Molecular sequelae of histone deacetylase inhibition in human malignant B cells
Nicholas Mitsiades,Constantine S. Mitsiades,Paul G. Richardson,Ciaran McMullan,Vassiliki Poulaki,Galinos Fanourakis,Robert Schlossman,Dharminder Chauhan,Nikhil C. Munshi,Teru Hideshima,Victoria M. Richon,Paul A. Marks,Kenneth C. Anderson
PHAGOCYTES
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys
Jan Storek,Thurman Gillespy, III,Hailing Lu,Ansamma Joseph,Monja A. Dawson,Michael Gough,Julia Morris,Robert C. Hackman,Peter A. Horn,George E. Sale,Robert G. Andrews,David G. Maloney,Hans-Peter Kiem
Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma
Brief Report
Shinya Kimura,Akeyo Horie,Yoshiyuki Hiki,Chie Yamamoto,Satoru Suzuki,Junya Kuroda,Masayo Deguchi,Gen-ichi Kato,Takahiro Karasuno,Akira Hiraoka,Toshikazu Yoshikawa,Taira Maekawa
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals